Transcatheter closure has been widely accepted as a highly effective way to treat abnormal
blood flows and/or embolization of thrombus in the heart. It allows the closure of four types of …

Aim The Occlutech duct occluder (ODO) with a novel design has been available for closure
of patent ductus arteriosus (PDA) since 2011. Available data on initial experience with the …

Aim To describe our initial experience with the indications and results of the 5/7 Occlutech®
duct Occluder (ODO, Occlutech International AB, Helsingborg, Sweden). A small incremental …

Objective: to report a case of deformation of a relatively new type of device for closure of
patent ductus arteriosus. Method: we report the case of an adult patient with hypertensive …

Pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD) is
one type under group 1 PH. Undiagnosed or delayed diagnosis of significant CHD might …

动脉导管未闭(PDA) 是儿童常见先天性血管畸形之一, 正常情况下, 在生后3 个月内解剖关闭,
但由于动脉导管在生后持续存在, 导致左向右分流, 引起一系列并发症, 如充血性心力衰竭等 …

Objetivo: Presentar la experiencia en un país andino con el dispositivo OcclutechTM Duct
Occluder para el cierre del conducto arterioso persistente. Método: Estudio observacional …

Background The traditional approach for adult congenital heart disease combined with
valvular disease is surgical treatment under cardiopulmonary bypass (CPB). This approach …

RIOS-MENDEZ, Raúl E. et al. Closure of patent ductus arteriosus with Occlutech TM device,
experience in an andean country. Arch. Cardiol. Méx.[online]. 2024, vol. 94, n. 2, pp. 169 …

Objectives: We aim to describe the efficacy, safety, and characteristics of the Amplatzer
Vascular Plug (AVP) II and IV “off-label” use for multiple cardiovascular occlusions in …